We are live on
!
Find out more
RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
36 hedge funds and large institutions have $18.1M invested in Regulus Therapeutics in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 15 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 5
90% more capital invested
Capital invested by funds: $9.54M → $18.1M (+$8.54M)
2.09% more ownership
Funds ownership: 2.07% → 4.16% (+2.1%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
3% less funds holding
Funds holding: 37 → 36 (-1)
Holders
36
Holders Change
-1
Holders Change %
-2.7%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
15
Reduced
5
Closed
3
Calls
$195K
Puts
–
Net Calls
+$195K
Net Calls Change
+$126K
Top Buyers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$7.56M |
| 2 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$2.08M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$169K |
| 4 |
Renaissance Technologies
New York
|
+$28.9K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$17.1K |
Top Sellers
| 1 |
EAM
Empery Asset Management
New York
|
-$1.6M |
| 2 |
Morgan Stanley
New York
|
-$2K |
| 3 |
GFS
GYL Financial Synergies
West Hartford,
Connecticut
|
-$1.82K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$1.64K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$572 |
